Tsuboi Y - Search Results

1

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.

Tsuboi Y, Ahlskog JE, Apaydin H, Parisi JE, Dickson DW. Tsuboi Y, et al. Neurology. 2001 Nov 13;57(9):1675-8. doi: 10.1212/wnl.57.9.1675. Neurology. 2001. PMID: 11706110

2

Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.

Wszolek ZK, Tsuboi Y, Uitti RJ, Reed L, Hutton ML, Dickson DW. Wszolek ZK, et al. Among authors: tsuboi y. Brain. 2001 Aug;124(Pt 8):1666-70. doi: 10.1093/brain/124.8.1666. Brain. 2001. PMID: 11459757 No abstract available.

3

High serum pancreatic secretory trypsin inhibitor before onset of type II citrullinemia.

Tsuboi Y, Fujino Y, Kobayashi K, Saheki T, Yamada T. Tsuboi Y, et al. Neurology. 2001 Sep 11;57(5):933. doi: 10.1212/wnl.57.5.933. Neurology. 2001. PMID: 11552040 No abstract available.

4

Japanese family with parkinsonism, depression, weight loss, and central hypoventilation.

Tsuboi Y, Wszolek ZK, Kusuhara T, Doh-ura K, Yamada T. Tsuboi Y, et al. Neurology. 2002 Apr 9;58(7):1025-30. doi: 10.1212/wnl.58.7.1025. Neurology. 2002. PMID: 11940687

5

Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family.

Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Tsuboi Y, et al. Arch Neurol. 2002 Jun;59(6):943-50. doi: 10.1001/archneur.59.6.943. Arch Neurol. 2002. PMID: 12056930

6

Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.

Kobayashi T, Mori H, Okuma Y, Dickson DW, Cookson N, Tsuboi Y, Motoi Y, Tanaka R, Miyashita N, Anno M, Narabayashi H, Mizuno Y. Kobayashi T, et al. Among authors: tsuboi y. J Neurol. 2002 Jun;249(6):669-75. doi: 10.1007/s00415-002-0687-3. J Neurol. 2002. PMID: 12111297

7

[Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy].

Fujino Y, Nakajima M, Tsuboi Y, Baba Y, Yamada T. Fujino Y, et al. Among authors: tsuboi y. Rinsho Shinkeigaku. 2002 Jan;42(1):42-4. Rinsho Shinkeigaku. 2002. PMID: 12355852 Japanese.

8

A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.

Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW. Josephs KA, et al. Among authors: tsuboi y. Arch Neurol. 2002 Oct;59(10):1597-601. doi: 10.1001/archneur.59.10.1597. Arch Neurol. 2002. PMID: 12374498

9

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).

Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, Soulages X, Murrell JR, Ghetti B, Yasuda M, Komure O, Kuno S, Arima K, Sunohara N, Kobayashi T, Mizuno Y, Wszolek ZK. Tsuboi Y, et al. Neurology. 2002 Dec 10;59(11):1791-3. doi: 10.1212/01.wnl.0000038909.49164.4b. Neurology. 2002. PMID: 12473774

10

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Tsuboi Y, Josephs KA, Cookson N, Dickson DW. Tsuboi Y, et al. Neurology. 2003 Jan 28;60(2):240-5. doi: 10.1212/01.wnl.0000044340.37138.a9. Neurology. 2003. PMID: 12552038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters